



| Revenue | $100 - $500 million See Exact Annual Revenue |
|---|---|
| Employees | 500 - 1,000Exact Company Size |
| Primary Industry | 5411 Legal Services |
| Additional NAICS Codes | 621511 Medical Laboratories |
| Address | Suite 201 820, South Friendswood Drive Friendswood, TX 77546 |
| Castle Biosciences | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
|---|---|---|---|
| 2025 | $100 - $500 million Details in Premium Report | ||
| 2024 | |||
| 2023 | |||
| 2021 | |||
| 2020 | |||
| 2019 | |||
|
1-Year Growth Rate: 3-Year Growth Rate (CAGR): | ![]() |
| Castle Biosciences P&L | $ Millions |
|---|---|
| Revenue (Sales) | ![]() |
| Cost of Goods Sold | |
| Gross Profit | |
Operating Expenses | |
| Advertising | |
| Salaries and wages | |
| Other Operating Expenses | |
| Total Operating Expenses | |
| Operating Income | |
| EBITDA | |
| EBIT (Earnings Before Interest and Taxes) | |
| Net Profit | |
| Date | Investors | Percent Raised | Target Size |
|---|---|---|---|
| July 30, 2019 | 1 | 50% | $20 MM |
| Complete list of funding rounds and total amounts in the Company Report | |||
| Trademark | Date |
|---|---|
| I-GEP Medical testing for diagnostic or treatment purposes; Medical testing for diagnostic or treatment purposes in the field of integrating the pathology of a tumor, mycotic activity and thickness with a gene expression test using artificial intelligence | 04/14/2021 |
| RISK IDENTIFIED Downloadable software in the nature of a mobile application for risk prediction to illustrate the likelihood of sentinel lymph node positivity for a specific patient with cancer invasive melanoma and or sentinel lymph node positivity with invasive melanoma using an artificial intelligence-based, neural network | 04/08/2021 |
| DIFFDX Providing medical diagnostic testing services to dermatologists, surgeons, and oncologists for diagnostic and prognostic purposes for dermatologic melanoma, namely genetic expression profiling and gene sequencing using a neural network, artificial intelligence-designed algorithm relating to dermatological melanoma, and providing medical information based on the expression | 11/10/2020 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| AUSTIN 316 FIDUCIARY LIMITED | Oceanside, NY | 100 |
| CONSILIO | Washington, DC | 66 |
| LATHAM & WATKINS | Los Angeles, CA | 54 |
| KIRKLAND & ELLIS | Chicago, IL | 49 |
| CO STATE FRATERNAL ORDER OF POLICE | Westminster, CO | 44 |
| GREENBERG TRAURIG P.A. | Miami, FL | 42 |
| PROFESSIONAL LAW ENFORCEMENT A | Rochester, MI | 38 |
| CHG COMPANIES | Midvale, UT | 35 |
| BAKER & MCKENZIE | Chicago, IL | 33 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| BETTISON DOYLE APFFEL & GUARINO PC | Galveston, TX | 100 |
| DOYLE LAW FIRM PLLC | Galveston, TX | 75 |
| GREER HERZ & ADAMS | Galveston, TX | 32 |
| POTTER HANDY | Friendswood, TX | 24 |
| GREER HERTZ & ADAMS | Galveston, TX | 22 |
| SCOTT M. BROWN ATTORNEY P.C. | Angleton, TX | 19 |
| Company | Revenue ($ MM) |
|---|---|
![]() | |